Results 191 to 200 of about 322,587 (327)

Natural Sweetener Stevioside‐Based Dissolving Microneedles Solubilize Minoxidil for the Treatment of Androgenic Alopecia

Advanced Healthcare Materials, EarlyView.
This study addresses limitations of minoxidil (MXD) in treating androgenetic alopecia by using stevioside (STV) as a solubilizing agent and microneedle (MN) material. STV enhanced MXD's solubility and skin absorption, leading to improved drug delivery and significant hair regrowth in animal models, demonstrating strong potential for AGA treatment ...
Junying Zhang, Tianyu Shao, Hailiang Li, Luying Zhu, Lamyaa Albakr, Nial J. Wheate, Lifeng Kang, Chungyong Wu   +7 more
wiley   +1 more source

Angiogenesis Inhibitors for Colorectal Cancer. A Review of the Clinical Data. [PDF]

Cancers (Basel), 2021
Hansen TF, Qvortrup C, Pfeiffer P.
europepmc   +1 more source

Decellularized Extracellular Matrix (dECM) in Tendon Regeneration: A Comprehensive Review

Advanced Healthcare Materials, EarlyView.
Decellularized Extracellular Matrix (dECM) offers a promising solution by replicating the native tendon microenvironment and promoting regeneration. This review highlights advances in the decellularization methods, as well as their integration with emerging technologies and translational progress in tendon tissue engineering.
Kumaresan Sakthiabirami, Yeonwoo Park, Seong Kyeong Jo, Min Hee Kim, Jae Hwang Song   +4 more
wiley   +1 more source

Cardiovascular toxicity associated with angiogenesis inhibitors: A comprehensive pharmacovigilance analysis based on the FDA Adverse Event Reporting System database from 2014 to 2021. [PDF]

Front Cardiovasc Med, 2022
Wang Y, Cui C, Ren X, Dong X, Cui W.
europepmc   +1 more source

Ethoxy-erianin phosphate inhibits angiogenesis in colorectal cancer by regulating the TMPO-AS1/miR-126-3p/PIK3R2 axis and inactivating the PI3k/AKT signaling pathway

Shaoqun Liu, Fei Teng, Yuxin Lu, Yanqing Zhu, Xin Liang, Fanhong Wu, Jianwen Liu, Wenming Zhou, Chang Su, Yiou Cao   +9 more
openalex   +1 more source

Angiogenesis inhibitors in clinical development; where are we now and where are we going?

, 2004
Ferry A.L.M. Eskens
openalex   +1 more source

RETRACTED ARTICLE: Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway [PDF]

, 2019
Jun Dai, Rujia Wei, Peihai Zhang, Beihua Kong   +3 more
openalex   +1 more source

Supplementary Table from Functional Characterization of <i>lncRNA152</i> as an Angiogenesis-Inhibiting Tumor Suppressor in Triple-Negative Breast Cancers

, 2023
Dae-Seok Kim, Cristel V. Camacho, Rohit Setlem, Kangsan Kim, Srinivas Malladi, Tim Y. Hou, Tulip Nandu, Shrikanth S. Gadad, W. Lee Kraus   +8 more
openalex   +1 more source

Advances in Bioprinting to Model Immune‐Mediated Skin Diseases

Advanced Healthcare Materials, EarlyView.
This review explores how 3D bioprinting drives innovation in developing in vitro skin models that mimic immune‐mediated diseases. It highlights current technologies, key applications in studying skin pathologies, and emerging challenges. The review points toward future opportunities for improving disease modeling and advancing therapeutic and cosmetic ...
Andrea Ulloa‐Fernández, Marica Markovic, Julia Fernández‐Pérez, Georg Stary, Aleksandr Ovsianikov   +4 more
wiley   +1 more source

Thromboembolic events associated with angiogenesis inhibitors: a real-world study of data from the food and drug administration adverse event reporting system (FAERS) database. [PDF]

Thromb J
Zhou J, Wu M, Chen T, Niu P, Zhu Y, Liu Y, Chen H, Zeng X, Zhang J.   +8 more
europepmc   +1 more source